The emerging role of FKBP5 in the regulation of metabolism and body weight

Surgery for Obesity and Related Diseases

Volumn 12, Issue 8, 2016, Pages 1560-1561

  Zannas, Anthony S ^a,b   Balsevich, Georgia ^a   Gassen, Nils C ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; UNCLASSIFIED DRUG;

AUTOPHAGY; BARIATRIC SURGERY; BODY WEIGHT; BRAIN REGION; CARDIOVASCULAR RISK; DIET RESTRICTION; EDITORIAL; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID DIET; MENTAL STRESS; METABOLIC DISORDER; METABOLIC REGULATION; NEGATIVE FEEDBACK; OBESITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION; ZONA INCERTA; MORBID OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM;

HUMANS; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84997107089     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.05.016     Document Type: Editorial

References (12)

1. [1] Swinburn, B.A., Sacks, G., Hall, K.D., et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:9793 (2011), 804–814.
2. [2] O׳Rahilly, S., Human genetics illuminates the paths to metabolic disease. Nature 462:7271 (2009), 307–314.
3. [3] Hartmann, I., Fries, G.R., Bücker, J., Scotton, E., von Diemen, L., Kauer-Sant׳Anna, M., The FKBP5 polymorphism rs1360780 is associated with lower weight loss after bariatric surgery: 26 months of follow-up. In press Surg Obes Relat Dis., 2016.
4. [4] Zannas, A.S., Wiechmann, T., Gassen, N.C., Binder, E.B., Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology 41:1 (2016), 261–274.
5. [5] Binder, E.B., Salyakina, D., Lichtner, P., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36:12 (2004), 1319–1325.
6. [6] Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F., Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280:6 (2005), 4609–4616.
7. [7] Kaltsas, G., Zannas, A.S., Chrousos, G.P., Hypothalamic-pituitary-adrenal axis and cardiovascular disease. Hjemdahl, P., Rosengren, A., Steptoe, A., (eds.) Stress and cardiovascular disease, 2012, Springer, London, UK.
8. [8] Pei, H., Li, L., Fridley, B.L., et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16:3 (2009), 259–266.
9. [9] Gassen, N.C., Hartmann, J., Zschocke, J., et al. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS Med, 11(11), 2014, e1001755.
10. [10] Su, A.I., Wiltshire, T., Batalov, S., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101:16 (2004), 6062–6067.
11. [11] Pereira, M.J., Palming, J., Svensson, M.K., et al. FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance. Metabolism 63:9 (2014), 1198–1208.
12. [12] Balsevich, G., Uribe, A., Wagner, K.V., et al. Interplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51. J Endocrinol 222:1 (2014), 15–26.